Aristotle University Of Thessaloniki (AUTH)
Σύγχρονες προσεγγίσεις στο σχεδιασμό και στην ανάπτυξη αντιφλεγμονωδών ενώσεων
Abstract
dc:descriptionNon-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used agents for the treatment of inflammation and very frequently prescribed medications. However, they possess major and even life-threatening side effects, such as damage to the gastric mucosa, renal failure and prolongation of bleeding time. Several strategies have been followed to reduce these adverse effects with moderate results. A more recent and promising approach is that of COX-2 inhibitors. It is found that prostaglandins, important for the gastrointestinal and renal function, are produced via COX-1, which is the constitutive isoform of COX, and prostaglandins responsible for inflammation are produced via COX-2, the inducible isoform of the enzyme. Therefore, an effort has been made for the development of COX-2 selective inhibitors, in order to suppress only the production of prostaglandins that mediate inflammation. These drugs are currently on market and are considered gastrointestinal (GI) fairly safe and potent anti-inflammatory agents, but recent studies prove that they still have some important disadvantages. Another approach to reduce the toxicity of NSAIDs is the linking of a nitric monoxide (NO) releasing moiety to these compounds, thus, a new category of anti-inflammatory agents is emerging, the NO-NSAIDs. Nitric oxide is a small diatomic radical which plays an important physiological role in nervous, cardiovascular and immune systems. Its generation is controlled by the three isoforms of NO synthases (NOS), neuronal and endothelial NOS (nNOS and eNOS), which are constitutive and produce nanomolar amounts of NO important for normal cell function and tissue protection, and inducible NOS (iNOS) which generates high amounts of NO responsible for the destruction of invading pathogens as part of an overall inflammatory response. The endogenous tissue NO, generated constitutively by GI eNOS and nNOS, appears to play a key role in the chronic maintenance of gastrointestinal tissue integrity and in adaptive cytoprotection to injurious stimuli, perhaps acting synergistically with other cytoprotective prostaglandins. NO promotes several gastric defense mechanisms. In addition, NO may reduce inflammation connected to oxidative stress by scavenging reactive oxygen species which can adversely increase mucosal permeability and kill cells. Furthermore, it is found that NO and NO-derived reactive nitrogen species interact with peroxidases and lipoxygenases, altering the generation of prostaglandins and leukotrienes, which are signaling molecules involved in inflammation.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ζιάκας, Γεώργιος
- Ziakas, Georgios
Subjects
dc:subject × 16- Αντιφλεγμονώδεις ενώσεις
- Δότες μονοξειδίου του αζώτου
- Αντιοξειδωτικά
- Εστέρες τολφαιναμικού οξέος
- Παράγωγα 2,6-δι-τερτ- βουτυλοφαινόλης
- Αναστολή κυκλοοξυγονάσης / λιποξυγονάσης
- Anti-inflammatory agents
- Nitric oxide donors
- Antioxidants
- Tolfenamic
- 2,6-di-tert- butylphenol derivatives
- Cyclooxygenase / lipoxygenase inhibition
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/14654